Mendiola C - Search Results

1

Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.

Sánchez-Muñoz A, Mendiola C, Pérez-Ruiz E, Rodríguez-Sánchez CA, Jurado JM, Alonso-Carrión L, Ghanem I, de Velasco G, Quero-Blanco C, Alba E. Sánchez-Muñoz A, et al. Among authors: mendiola c. Oncology. 2010;79(1-2):98-104. doi: 10.1159/000320602. Epub 2010 Nov 15. Oncology. 2010. PMID: 21079407

2

Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.

Cervantes A, Mendiola C, del Campo JM, Massuti B, Casado A, Escobedo A, Moyano A, Ojeda B, Poveda A, Benito D. Cervantes A, et al. Among authors: mendiola c. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43. Semin Oncol. 1997. PMID: 9346221 Clinical Trial.

3

Update in the management of ovarian and cervical carcinoma.

Poveda A, Salazar R, del Campo JM, Mendiola C, Cassinello J, Ojeda B, Arranz JA, Oaknin A, García-Foncillas J, Rubio MJ, González Martín A. Poveda A, et al. Among authors: mendiola c. Clin Transl Oncol. 2007 Jul;9(7):443-51. doi: 10.1007/s12094-007-0083-7. Clin Transl Oncol. 2007. PMID: 17652058

4

Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma.

García-Velasco A, Mendiola C, Sánchez-Muñoz A, Ballestín C, Colomer R, Cortés-Funes H. García-Velasco A, et al. Among authors: mendiola c. Clin Transl Oncol. 2008 Jun;10(6):367-71. doi: 10.1007/s12094-008-0213-x. Clin Transl Oncol. 2008. PMID: 18558584

5

Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.

Pérez-Regadera J, Sánchez-Muñoz A, De-la-Cruz J, Ballestín C, Lora D, García-Martín R, Mendiola C, Alonso L, Alba E, Lanzós E. Pérez-Regadera J, et al. Among authors: mendiola c. Oncology. 2009;76(2):133-41. doi: 10.1159/000195539. Epub 2009 Jan 28. Oncology. 2009. PMID: 19174612

6

Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis.

Mendiola C, Vaz MA. Mendiola C, et al. Clin Transl Oncol. 2009 Aug;11(8):554-7. doi: 10.1007/s12094-009-0403-1. Clin Transl Oncol. 2009. PMID: 19661033

7

Cisplatin-based radiochemotherapy improves the negative prognosis of c-erbB-2 overexpressing advanced cervical cancer.

Pérez-Regadera J, Sánchez-Muñoz A, De-la-Cruz J, Ballestín C, Lora D, García-Martín R, Alonso-Carrión L, Mendiola C, Lanzós E. Pérez-Regadera J, et al. Among authors: mendiola c. Int J Gynecol Cancer. 2010 Jan;20(1):164-72. doi: 10.1111/IGC.0b013e3181ad3e11. Int J Gynecol Cancer. 2010. PMID: 20057287 Clinical Trial.

8

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

Manso L, Valdiviezo N, Sepúlveda J, Ciruelos E, Mendiola C, Ghanem I, Vega E, Manneh R, Dorta M, Cortés-Funes H. Manso L, et al. Among authors: mendiola c. Clin Transl Oncol. 2013 Jun;15(6):467-71. doi: 10.1007/s12094-012-0954-4. Epub 2012 Dec 21. Clin Transl Oncol. 2013. PMID: 23263907

9

Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer.

Sotelo MJ, García-Sáenz JA, Manso L, Moreno F, Ciruelos E, Callata HR, Mendiola C, Cabezas S, Ghanem I, Díaz-Rubio E. Sotelo MJ, et al. Among authors: mendiola c. J Cancer Res Ther. 2014 Oct-Dec;10(4):967-72. doi: 10.4103/0973-1482.138017. J Cancer Res Ther. 2014. PMID: 25579538 Free article.

10

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M. Blancas I, et al. Among authors: mendiola c. Clin Transl Oncol. 2018 Jul;20(7):862-869. doi: 10.1007/s12094-017-1797-9. Epub 2017 Nov 24. Clin Transl Oncol. 2018. PMID: 29178019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters